We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $404M
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+28.4%
3 Year Est. Return
+72.33%
5 Year Est. Return
+90.54%
10 Year Est. Return
+313.33%
AUM
$328M
AUM Growth
-$9.02M
Cap. Flow
-$9.59M
Cap. Flow %
-2.92%
Top 10 Hldgs %
36.34%
Holding
213
New
5
Increased
48
Reduced
109
Closed
12

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.61%
2 Technology 16.85%
3 Healthcare 16.12%
4 Financials 14.31%
5 Industrials 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABEV icon
201
Ambev
ABEV
$46.6B
$80.3K 0.02%
34,480
ALB icon
202
Albemarle
ALB
$13.4B
-2,883
Closed -$248K
CRL icon
203
Charles River Laboratories
CRL
$13B
-5,223
Closed -$964K
CVS icon
204
CVS Health
CVS
$121B
-14,407
Closed -$647K
DELL icon
205
Dell
DELL
$346B
-1,877
Closed -$216K
FSLR icon
206
First Solar
FSLR
$21.7B
-1,158
Closed -$204K
ILMN icon
207
Illumina
ILMN
$33.6B
-2,670
Closed -$357K
MORN icon
208
Morningstar
MORN
$7.57B
-610
Closed -$205K
NBIX icon
209
Neurocrine Biosciences
NBIX
$15.2B
-1,492
Closed -$204K
OGN icon
210
Organon & Co
OGN
$3.59B
-13,826
Closed -$206K
TROW icon
211
T. Rowe Price
TROW
$22.2B
-1,875
Closed -$212K
UFPI icon
212
UFP Industries
UFPI
$4.55B
-1,788
Closed -$201K
USLM icon
213
United States Lime & Minerals
USLM
$3.38B
-2,300
Closed -$305K

Similar funds

Roberts, Glore & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Roberts, Glore & Co held 213 positions worth $328M, down 2.7% from $337M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Roberts, Glore & Co's Q1 2025 filing shows 5 new, 48 increased, 109 reduced and 12 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 12,006 shares worth $981K. The largest sale was Berkshire Hathaway Class B, an estimated $1.56M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Roberts, Glore & Co's largest Q1 2025 buy was iShares MSCI EAFE ETF: 12,006 shares worth $981K.
  • Roberts, Glore & Co added most to Vanguard S&P 500 ETF in Q1 2025, an estimated $747K increase.
  • Roberts, Glore & Co's biggest Q1 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $1.56M.
  • Roberts, Glore & Co fully exited Charles River Laboratories in Q1 2025, selling an estimated $964K.
  • Roberts, Glore & Co's ten largest holdings make up 36% of its $328M portfolio in Q1 2025.
  • Roberts, Glore & Co opened 5 new positions and closed 12 in Q1 2025.
  • Roberts, Glore & Co's portfolio value fell 2.7% quarter-over-quarter to $328M.

Based on Roberts, Glore & Co's 13F filing for Q1 2025, filed 9 May 2025.